Opening Ceremony - M B Agarwal
CLL - Transition to a New Era: Current standard of care and the evolving role of novel therapies - Dr. Stephen Mulligan
CLL with del17p: Treatment with Ibrutinib How to follow up? - Dr Anupam Chakrapani
CLL/PLL with t(11;14) -treatment dilemmas! - Sharat Damodar
Treatment of Mantle cell Iymphoma - Dr. T P Sahoo
Ibrutinib as a Bridge to Allo SCT - Dr. Dinesh Bhurani
Mantle Cell LymphomaOther Novel Therapies - Dr. Maitreyee Bhattacharyya
Management of the Elderly Patient with CLL -Dr. Stephen Mulligan
Diagnosing GCB Vs ABC subtypes & importance of Grey Zone Lymphoma - Dr. Pankaj Malhotra
Ibrutinib in DLBCL? - Dr. Prashant Mehta
Other novel therapies - Dr. Bhausaheb Bagal
Role of stem cell transplantation in High risk CLL - Dr. Biju George
Case of CLL/SLL with hypogammaglobulinemia - Dr. Ashish Dixit
Chronic Lymphocytic Leukaemia Trials in Australia - Dr. Stephen Mulligan